With the analysis among 3,124 patents, we discovered top 440 key players by total patent application. EIDP, Inc., GE Healthcare Ltd. (United Kingdom), Epimmune, Inc. are dominant in this area. They take 9.80% of the total patent filing.
Delaware, United States
Patent: 143
GE Healthcare Ltd. (United Kingdom)
Buckinghamshire, United Kingdom
Patent: 83
California, United States
Patent: 80
California, United States
Patent: 61
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 57
California, United States
Patent: 56
NOTTINGHAM, United Kingdom
Patent: 52
Cidara Therapeutics, Inc.
California, United States
Patent: 48
Massachusetts, United States
Patent: 47
New Hampshire, United States
Patent: 43
With the analysis among 72 patents, we discovered top 15 start-ups by total patent application. ALX Oncology, Inc., Pinetree Therapeutics, Inc., Theradaptive, Inc. are active in this area.
California, United States
Patent: 22
Pinetree Therapeutics, Inc.
Massachusetts, United States
Patent: 9
Massachusetts, United States
Patent: 9
Epsilon Molecular Engineering, Inc.
Saitama-ken, Japan
Patent: 8
California, United States
Patent: 6
Institut National de la Santé et de la Recherche Médicale
Targimmune Therapeutics AG
Basel-Stadt, Switzerland
Patent: 4
Cambridgeshire, United Kingdom
Patent: 2
Gyeonggi-do, South Korea
Patent: 2
NeoCura Bio-Medical Technology Co., Ltd.
Guangdong Sheng, China
Patent: 1
With the analysis among related 910 patents applied in the last 5 years. We discover 301 most active companies in this area. The fast-growing Cidara Therapeutics, Inc., Immatics Biotechnologies GmbH, Kagoshima University take 10.99% of patent filing during this period.
Cidara Therapeutics, Inc.
California, United States
Patent: 48
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 26
Kagoshima-ken, Japan
Patent: 26
New Jersey, United States
Patent: 19
Regents of the University of California
California, United States
Patent: 18
Vasomune Therapeutics, Inc.
Ontario, Canada
Patent: 18
Tokyo-to, Japan
Patent: 18
Tokyo-to, Japan
Patent: 15
National Research Council of Canada
Ontario, Canada
Patent: 13
With the analysis among related 910 patents in last 5 years, we discover 187 new entrants. Cidara Therapeutics, Inc., Vasomune Therapeutics, Inc., Kao Corp. are the most active new entrants in this area.
Cidara Therapeutics, Inc.
California, United States
Patent: 48
Vasomune Therapeutics, Inc.
Ontario, Canada
Patent: 18
Tokyo-to, Japan
Patent: 15
National Research Council of Canada
Ontario, Canada
Patent: 13
Virginia, United States
Patent: 9
Texas, United States
Patent: 9
Massachusetts, United States
Patent: 9
JCR Pharmaceuticals Co., Ltd.
With the analysis among 1,361 patents, we discovered top 172 universities and scientific research institutions by total patent application. Kagoshima University, Massachusetts Institute of Technology, The University of North Carolina at Chapel Hill are dominant in this area. They take 15.80% of the total patent filing.
Kagoshima-ken, Japan
Patent: 60
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 51
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 27
Illinois, United States
Patent: 25
Washington University in St. Louis
Missouri, United States
Patent: 19
Alabama, United States
Patent: 18
The Johns Hopkins University
Washington, United States
Patent: 14
Vrije Universiteit Brussel
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 13
Morehouse School of Medicine
Georgia, United States
Patent: 13